focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBelluscura Regulatory News (BELL)

Share Price Information for Belluscura (BELL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 16.50
Ask: 17.50
Change: 1.25 (7.94%)
Spread: 1.00 (6.061%)
Open: 15.75
High: 17.75
Low: 15.25
Prev. Close: 15.75
BELL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

5 Apr 2024 15:48

RNS Number : 5594J
Belluscura PLC
05 April 2024
 

5 April 2024

 

 

BELLUSCURA PLC

 

Recommended all-share offer for TMT Acquisition plc by Belluscura plc

 

Issue of Equity

 

On 19 January 2024, the Board of Belluscura plc ("Belluscura") and the independent director of TMT Acquisition plc ("TMT Acquisition") announced the revised terms of the recommended all share offer to be made by Belluscura for the whole of the issued share capital of TMT Acquisition (the "Offer"), originally announced on 31 October 2023. The full terms and conditions of the Offer were set out in the offer document dated 19 January 2024 (the "Offer Document").

 

Belluscura announced on 9 February 2024 that the Offer had become wholly unconditional and the Offer closed ion 8 March 2024.

 

As previously announced the Company has on 22 February 2024 formal compulsory acquisition notices under section 979n of the Companies Act 2006 (as amended) were sent to all TMT Acquisition Shareholders who at that date had not accepted the Offer, for the compulsory acquisition by Belluscura of all the TMT Acquisition Shares owned by such TMT Acquisition Shareholders on the same terms of the Offer. 

 

The Compulsory Acquisition process has now concluded and the Company has today issued and allotted a further 647,450 New Belluscura Shares in consideration of the TMT Acquisition shares acquired through the compulsory acquisition.

 

Application has been made for these New Belluscura Shares to be admitted to be admitted to trading on AIM ("AIM Admission") and AIM Admission is expected to take place at 8.00am on Monday 8 April 2024. The New Belluscura Shares will rank pari passu in all respects with Belluscura existing ordinary shares.

 

Belluscura Total Voting Rights

 

The total number of ordinary shares of 1 penny each in Belluscura now in issue is 165,032,567 with International Securities Identification Number (ISIN) GB00BD3B8Z11.

 

There are no ordinary shares held in treasury and therefore the total number of voting rights in Belluscura is 165,032,567. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Belluscura under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

Belluscura plc

Adam Reynolds

 

via MHP Group

Dowgate Capital Limited - Financial Advisor and Broker to Belluscura

Russell Cook / Nicholas Chambers

 

+44 (0)20 3903 7715

SPARK Advisory Partners Limited - Nominated Advisor to Belluscura

Neil Baldwin / Jade Bayat

 

+44 (0)20 3368 3554

MHP Group - Financial PR & Investor Relations to Belluscura

Katie Hunt / Matthew Taylor

 

Belluscura@mhpgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEEALLSELSLEFA
Date   Source Headline
10th Oct 20234:19 pmRNSForm 8.3 - TMT Acquisition PLC
10th Oct 20233:54 pmRNSForm 8.3 - Belluscura plc
10th Oct 20233:52 pmRNSForm 8.3 - Belluscura plc
10th Oct 20233:47 pmRNSForm 8.3 - Belluscura plc
10th Oct 20233:45 pmRNSForm 8.3 - Belluscura plc
10th Oct 20233:45 pmRNSForm 8.3 - Belluscura plc
10th Oct 20233:42 pmRNSForm 8.3 - Belluscura plc
10th Oct 20233:28 pmGNWForm 8.3 - Belluscura PLC
9th Oct 20236:11 pmRNSForm 8.3 - Belluscura Plc
9th Oct 20232:32 pmRNSForm 8.3 - Belluscura PLC
9th Oct 20231:39 pmRNSRule 2.9 Announcement
9th Oct 20238:10 amRNSRule 2.9 Announcement
6th Oct 202312:48 pmRNSConditional Allotment and Issue of Placing
5th Oct 20234:49 pmRNSForm 8.3 - Belluscura PLC
3rd Oct 20236:28 pmRNSReplacement - Placing of Unsecured CLNs
3rd Oct 20231:53 pmRNSDirectorate Change
3rd Oct 20231:38 pmRNSPlacing of Unsecured Convertible Loan Notes
3rd Oct 20231:30 pmRNSStatement re Possible Offer
3rd Oct 20231:30 pmRNSStatement regarding possible offer
26th Sep 20237:00 amRNSBelluscura Receives Approval in Hong Kong
14th Sep 20234:26 pmRNSResult of AGM
13th Sep 20237:00 amRNSHalf-year Report
30th Aug 20237:00 amRNSBelluscura Enters Exclusive License Agreement
16th Aug 20237:00 amRNSOrders for over 6,500 DISCOV-R™ received
1st Aug 20237:00 amRNSBelluscura Signs Distribution Agreement
12th Jul 20237:00 amRNSNotice of AGM and Annual Report 2022
29th Jun 20237:00 amRNSBelluscura Commences Premarket Launch of DISCOV-R™
29th Jun 20237:00 amRNSFinal Results for the year ended 31 December 2022
15th Jun 20237:00 amRNSShare allotment; Director/PDMR Shareholding; Appt.
14th Jun 202312:28 pmRNSResult of General Meeting
1st Jun 20237:00 amRNSResult of Retail Offer
26th May 20237:00 amRNSProposed Board Appointment
25th May 202311:15 amRNSRetail Offer to raise up to £0.5m
25th May 202311:00 amRNSProposed Placing and Subscriptions to raise £3.0m
28th Apr 20237:00 amRNSAdditional Broker Option - Extension
20th Apr 20238:19 amRNSExercise of Warrants and Total Voting Rights
3rd Apr 20237:00 amRNSBelluscura begins manufacturing in China
30th Mar 20237:00 amRNSChange of Auditor
24th Feb 20237:00 amRNSBelluscura POC now marketed through GoodRx®
16th Feb 202311:59 amRNSResult of General Meeting
10th Feb 20237:00 amRNSResult of Broker Option
31st Jan 20233:41 pmRNSPosting of Circular
27th Jan 20232:00 pmRNSPrice Monitoring Extension
27th Jan 202312:41 pmRNSPlacing of Unsecured Convertible Loan Notes
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSBelluscura appoints Senior VP of Global Sales
13th Jan 20237:00 amRNSYear-end Trading Update
11th Jan 20234:40 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.